NewTimeSpace News: In August 2026, Geely Automobile Holdings Limited (stock code: 00175) recorded total automobile sales of 270,194 units, up approximately 8% year on year, bringing cumulative sales in the first eight months of 2026 to 1,943,313 units, up approximately 2% year on year.
NewTimeSpace News: On 1 September 2026, NIMBLE HOLDINGS (00186.HK) announced the appointment of Dr. Chen Yuanzhi as an independent non-executive director for a three-year term with an annual remuneration of HKD 144,000; Dr. Chen currently serves as an independent director of several listed companies.
NewTimeSpace News: On 1 September 2026, the SFC announced that the shareholdings of RIVERINE CHINA (01417.HK) were highly concentrated as of 14 August 2026, with two major shareholders holding a combined 74.12% and, together with shares not deposited in the Central Clearing and Settlement System, accounting for 92.42% of the issued share capital, leaving only 7.58% held by other shareholders; the share price has surged 4,015% since 12 May 2026.
NewTimeSpace (newtimespace.com) News, on September 1, 2026, the chip theme weakened, and HUA HONG GRACE (01347.HK) fluctuated lower. As of 13:35, the stock was quoted at HKD 120.600, down 1.95%.
NewTimeSpace (newtimespace.com) News, on September 1, 2026, the robotics theme weakened, and MIDEA GROUP (00300.HK) fluctuated lower. As of 13:22, the stock was quoted at HKD 100.600, down 0.79%.
NewTimeSpace News: On 1 September 2026, NIO-SW (09866.HK) announced August deliveries of 35,836 vehicles, up 14.5% year on year, with cumulative deliveries of 1,260,485 vehicles; the 4,000th battery swap station, also the first fifth-generation station, was completed, and the all-new ES8 has completed 140,000 cumulative deliveries.
NewTimeSpace News: On 1 September 2026, XPENG-W (09868.HK) announced August deliveries of 39,107 new vehicles, up 4% year on year; its robotaxi business obtained the Guangzhou remote testing qualification for driverless road testing without a safety driver in the front seat, and the XPeng G9L made its debut and opened for pre-sale on 11 August.
NewTimeSpace News: On 1 September 2026, LI AUTO-W (02015.HK) announced August deliveries of 37,679 new vehicles, with cumulative deliveries of 1,801,834 vehicles; the new-generation flagship MPV Li MEGA will be launched on 2 September and the Li i9 in mid-September, and the Company will also commence sales in the Middle East market from Dubai.
NewTimeSpace (newtimespace.com) News,August 31, 2026, GLORY HEALTH(02329.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 139.54 million, decreased by 56.96% YoY
NewTimeSpace (newtimespace.com) News,August 31, 2026, HUAJIN INTL(02738.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 131.51 million, decreased by 82.06% YoY
NewTimeSpace (newtimespace.com) News, August 31, 2026, NOIZ GROUP(08163.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 7.62 million, decreased by 19.88% YoY
NewTimeSpace (newtimespace.com) News, August 31, 2026, CMBC CAPITAL(01141.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 302.02 million, increased by 10.54% YoY
NewTimeSpace (newtimespace.com) News,August 31, 2026, MAX SIGHT GROUP(08483.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at HKD 17.26 million, decreased by 34.01% YoY
NewTimeSpace News: On 31 August 2026, VONGROUP (00318.HK) announced that its FY2026 annual results are expected to be published before mid-September 2026, with the despatch of the annual report delayed accordingly; trading in its shares has been suspended since 3 August and will remain suspended until the annual results are published.
NewTimeSpace News: On 1 September 2026, BIDU-SW (09888.HK) announced that the conversion of its voluntary change from secondary listing to dual-primary listing has taken effect, with the Company now dual-primary listed on the Hong Kong Stock Exchange and the Nasdaq Global Select Market, and its ordinary shares and ADSs remain interchangeable.
NewTimeSpace News: On 1 September 2026, LAEKNA-B (02105.HK) announced that the first subject has been enrolled in the Phase I clinical study of LAE118, a novel PI3Kα pan-mutation selective inhibitor, for advanced solid tumours in China; the drug has received IND approval from the US FDA and CDE, and in June 2026 the Group entered into an exclusive licence agreement with Vasque Bio providing for payments of up to USD 527 million.
